TSX:LABS - Post Discussion
Post by
mdjbrown on Jun 10, 2024 10:22am
Companies already jockeying around versions of Epidiolex
https://dravetsyndromenews.com/news/avicanna-announces-canadian-launch-new-oral-cbd-formulation/ Would be interesting to hear more from Mr Pidduck regarding their agreement with AVCN, and if it includes CBD oral formulations similiar to Epidiolex......................
"Under the expanded Strategic Manufacturing Agreement, Avicanna intends to commercialize its proprietary SEDDS technology capsules, under the RHO Phyto brand, across domestic nation-wide medical channels including the Avicanna’s MyMedi.ca online cannabis care platform and MediPharm’s Canna farms platform. Additionally, MediPharm intends to commercialize the capsules across adult use wellness channels under its MediPharm Labs brand." https://www.avicanna.com/avicanna-and-medipharm-labs-expand-strategic-manufacturing-agreement-for-avicannas-proprietary-sedds-technology-capsules-for-canadian-and-international-markets/
Be the first to comment on this post